Outlook Therapeutics, Inc. · NASDAQ:OTLK
TANG CAPITAL MANAGEMENT, LLC reported a 6.40% stake in Outlook Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
TANG CAPITAL MANAGEMENT, LLC reported a 6.40% stake in Outlook Therapeutics, Inc., 1,682,502 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 6.40%
- Shares
- 1,682,502
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 6.40% | 1,682,502 |
| KEVIN TANG | 6.40% | 1,682,502 |
| TANG CAPITAL PARTNERS, LP | 5.90% | 1,555,862 |
| TANG CAPITAL PARTNERS III, INC | 0.50% | 126,640 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 |
Source
Related
- Outlook Therapeutics, Inc.
- Tang Capital Partners, LP
- Outlook Therapeutics, Inc. shareholders
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026